Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLOTIAZEPAM vs COAGULATION FACTOR VIIA RECOMBINANT HUMAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CLOTIAZEPAM vs COAGULATION FACTOR VIIA RECOMBINANT HUMAN: Safety Overview

Metric CLOTIAZEPAM COAGULATION FACTOR VIIA RECOMBINANT HUMAN
Total FAERS Reports 323 952
Deaths Reported 41 382
Death Rate 12.7% 40.1%
Hospitalizations 207 328
Average Patient Age 50.5 yrs 42.3 yrs
% Female Patients 59.2% 30.4%
Manufacturer N/A Laboratoire Franais du Fractionnement...
Route N/A INTRAVENOUS